did at 90 days postoperatively. No patients reported any worsening symptoms in either limb.
Objectives: The presence of a proximal venous outflow obstruction (PVOO) in the iliac vein has been observed during catheter-based interventions for acute deep venous thrombosis (DVT). It is not clear whether the proximal obstruction and the more distal DVT are causally related, even though stasis is a commonly known contributor to DVT. Stent placement in the iliac vein, an emerging intervention for chronic PVOO, has provided an unexpected opportunity to evaluate the relationship between PVOO in the iliac vein and DVT.
Methods: In order to evaluate a possible PVOO and DVT association, we retrospectively reviewed the medical records of 180 consecutive patients (mean age, 59 years; 57% females), with 90% presenting with edema and 10% presenting with active ulceration, who underwent iliac vein stent placement for chronic PVOO from October 2013 to March 2015. Of these, 152 had partial or complete panels for 48 separate markers of hypercoagulation. We divided the study patients into three groups: no known history of DVT, known history of DVT, and intraoperative findings of DVT as demonstrated by venogram and intravascular ultrasound imaging. Preoperative demographic and comorbidity data were analyzed using independent t-tests and c 2 tests. Focused hypercoagulation profiles consisting of 11 prominent indicators of hypercoagulation were extracted from the broader pool of 48 and used to perform a multiple logistic regression to identify potential predictors of DVT.
Results: A total of 77 patients (50.7%) were positive for DVT, but only 26 (17.1%) had a known history of DVT, while 71 (46.7%) had intraoperative findings of a remote DVT. c 2 Tests were significant for increased rates of intraoperative findings of remote DVT in patients with a history of DVT (81% vs 38%; P < .01). c 2 Tests were additionally significant for increased rates of DVT findings in patients with one or more positive hypercoagulation markers (67% vs 42%; P < .01). The most significant predictor for DVT in the logistic regression was a positive result for one of the 11 select hypercoagulation markers (n ¼ 148; odds ratio, 2.41; P ¼ .022).
Conclusions: PVOO in the iliac veins appears to be associated with DVT, with many of these DVT clinically silent to the patient. Several hypercoagulation markers were found to confer significant predictive value for DVT. This information may aid in management of DVT, PVOO, and patients undergoing vein stent placement for PVOO.
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Outcomes of Iliac Vein Stenting in Proximal Venous Outflow Obstruction
Sida Chen, Chien Yi M. Png, Jacob Lurie, Sneha Subramaniam, Charles Sanky, Michael Marin, Peter Faries, Windsor Ting. Icahn School of Medicine at Mount Sinai, New York, NY Objectives: This study evaluated the outcome of vein stent placement for chronic proximal venous outflow obstruction (PVOO) in order to improve patient selection, enhance technical approach, and better define quality measurements for these cases.
Methods: A total of 484 consecutive patients who underwent iliac vein stenting for PVOO from October 2013 to July 2016 were reviewed. Postoperative outcomes at 30 days, 60 days, 6 months, 1 year, and 1.5 years were analyzed. Wilcoxon-Mann-Whitney and Kruskal-Wallis tests were run for demographic/operative variables. Additionally, ordered logistic regressions were run for the outcomes at each time point.
Results: Follow-up was maintained in 90% of patients, with a mean follow-up time of 320 days. Mean patient age was 60 years, with 57% female. Edema was a symptom in 90.5% of patients and active ulceration in 10.7%. Kruskal-Wallis tests were significant for improvement in patients of all CEAP classes at 30 days (P ¼ .041), 90 days (P ¼ .045), 6 months (P ¼ .041), and 1 year (P ¼ .011). Ordered logistic regressions found the presence of edema (95% confidence interval [CI], 0.43-2.62; P ¼ .006), active ulceration (95% CI, 0.083-3.50; P ¼ .040), and decreased number of stents placed (95% CI, e1.07 to e 0.035; P ¼ .036) predicted increased improvement at 30 days, and a history of deep vein thrombosis (DVT; 95% CI, e1.79 to e 0.096; P ¼ .029) predicted decreased improvement at 1 year postoperatively (Table) . Bilateral vein stents comprised 59% of patients. Wilcoxon-Mann-Whitney tests were significant for more improvement in patients who had unilateral vs bilateral stents placed at 30 days (P ¼ .013) and 6 months (P ¼ .039). A total of 7.6% of patients underwent major postoperative reinterventions (61.7% for recurrent symptoms, 17.6% for persistent symptoms, 15% for new symptoms, and 6% for DVT). Mean time to reintervention was 191 days. The reintervention population was disproportionately composed of patients with a history of DVT (29.4%) and intraoperative DVT findings (47.1%) compared to the total patient population (13.8% and 21.5%, respectively).
Conclusions: Vein stent placement for PVOO is associated with beneficial outcomes >1 year after the procedure. While unilateral stents are associated with better outcomes, this may reflect less complex disease. The incidence of major secondary interventions is acceptable, with data pointing out indications that can serve as quality measurements in the future. The prevalence of history of DVT and intraoperative findings of DVT in the reintervention population is notable and would benefit from further study.
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Diagnosis and Surgical Management of 16 Cases of Inferior Vena Cava Leiomyomatosis
Methods: Between 2002 and 2015, 16 patients were evaluated for IVL at our medical center. Patient demographics, clinical variables, and perioperative outcomes were reviewed.
Results: All patients underwent B-mode ultrasound imaging, nine additionally underwent computed tomography (CT), and 10 patients received magnetic resonance imaging (MRI ; Fig, A) . A positive diagnosis was made by ultrasound imaging and MRI in all patients and by CT in 89% of patients. Surgery therapy was offered to 15 patients, 12 with a one-stage operative intervention, and three underwent a staged two-phase operative intervention (Fig B) . All patients recovered well, and IVL was confirmed by postoperative pathology. The 15 patients who underwent operation had the pathologic diagnosis of IVL. The specimens were covered by intimal-like tissue, 86.7% (13 of 15) of which was not significant adhere to venous wall, and 53.3% (8 of 15) of which had two and more lesions. Postoperative follow-up (range, 1-14 years; mean, 3.8 years) was performed by both a telephone follow-up call and as in-person outpatient follow-up. One patient who underwent a two-stage case relapsed, and radical surgery was performed again. One patient who deferred operative intervention and died 5 years following diagnosis of unknown cause.
Conclusions: Imaging examinations including B-mode ultrasound imaging, CT, and MRI are highly diagnostic for vena cava tumors such as leiomyomatosis. Surgical tumor removal and debulking via a one-stage or multistaged operative intervention is successful and has reasonable outcomes.
Author Disclosures: H. Fang: Nothing to disclose; B. Jin: Nothing to disclose; Y. Li: Nothing to disclose; P. Lv: Nothing to disclose; C. Yang: Nothing to disclose; Y. Yang: Nothing to disclose; M. A. Zayed: Nothing to disclose; H. Zheng: Nothing to disclose. is becoming a common treatment option for venous insufficiency. Treatment of venous insufficiency has been based on treatment of venous reflux. We examined the effect that iliac vein stenting had on reflux times prestenting and poststenting.
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Effect of Iliac Vein Stenting of NIVLs on Venous Reflux Times
Methods: From September 2012 to August 2016, we performed 1629 venograms with angioplasties and stenting of the iliac veins. These procedures were filtered to only include the venograms where a stent was placed, and no other vascular procedures were performed between "pre" and "post" infrarenal duplex venous mapping tests. This was done to ensure that the iliac vein stent placed was the only procedure affecting the venous reflux. This left a total of 515 procedures that were performed. Reflux was measured using ipsilateral ultrasound imaging.
Results: The average age of the patients were 64.68 years old (range, 24-95; standard deviation, 14.35), with 341 females and 173 males. The CEAP scores were C 2 (0.91%), C 3 (21.14%), C 4 (56.36%), C 5 (5.00%), and C 6 (16.59%). The Table reports the average reflux values, pre-/poststent, and the nonsignificant tendency of decrease in reflux.
Conclusions: There is no statistical significance between infrainguinal reflux times in the reflux time. These data suggest that the previously documented improvement in the patient's symptoms may be due to other mechanisms. 
